PIM1 and adult T-cell leukemia/lymphoma: Overexpression of PIM1 correlates with overexpression of STAT3 in ATLL patient samples, and treatment of ATLL cell lines with a Pim1 inhibitor, AZD1208, led to decreased proliferation, while treatment of ATLL mice with AZD1208 led to decreased tumor formation [81].